
|Videos|October 3, 2016
How Can Access to Costly Specialty Drugs be Improved?
Author(s)Lauren Santye, Assistant Editor
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Advertisement
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
Evaluating Pharmacists’ Role In Veterinary Medication Management and Education
4
Psychiatric Disorders Have Increased in More Recent Birth Cohorts, Study Suggests
5


























